Lupin Limited has informed the Exchange regarding a press release dated December 24, 2021, titled "Lupin Receives Tentative Approval from U.S. FDA for Azilsartan Medoxomil Tablets.".
Lupin Limited has informed the Exchange regarding a press release dated December 24, 2021, titled "Lupin Receives Tentative Approval from U.S. FDA for Azilsartan Medoxomil Tablets.".